Cited by 616Amyotrophic Lateral Sclerosis ResearchHereditary Neurological DisordersAlzheimer's disease research and treatments

The DOI matches its Crossref record; 201 of the 202 references it cites were found in a registry or an index.

Molecular pathways of motor neuron injury in amyotrophic lateral sclerosis

Open access

Ferraiuolo, Laura, Kirby, Janine, Grierson, Andrew J., Sendtner, Michael, Shaw, Pamela J.·2011·Nature Reviews Neurology

DOI 10.1038/nrneurol.2011.152

Open this paper in CoChat — free account

Abstract

Amyotrophic lateral sclerosis (ALS) is a genetically diverse disease. At least 15 ALS-associated gene loci have so far been identified, and the causative gene is known in approximately 30% of familial ALS cases. Less is known about the factors underlying the sporadic form of the disease. The molecular mechanisms of motor neuron degeneration are best understood in the subtype of disease caused by mutations in superoxide dismutase 1, with a current consensus that motor neuron injury is caused by a complex interplay between multiple pathogenic processes. A key recent finding is that mutated TAR DNA-binding protein 43 is a major constituent of the ubiquitinated protein inclusions in ALS, providing a possible link between the genetic mutation and the cellular pathology. New insights have also indicated the importance of dysregulated glial cell-motor neuron crosstalk, and have highlighted the vulnerability of the distal axonal compartment early in the disease course. In addition, recent studies have suggested that disordered RNA processing is likely to represent a major contributing factor to motor neuron disease. Ongoing research on the cellular pathways highlighted in this Review is predicted to open the door to new therapeutic interventions to slow disease progression in ALS.

Integrity signals

Registry

Crossref · 10.1038/nrneurol.2011.152

Cites

201 of 201 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

2 retracted

RETRACTED: Endoplasmic reticulum stress and induction of the unfolded protein response in human sporadic amyotrophic lateral sclerosis
Atkin, J. D., Farg, M. A., Walker, A. K., McLean, C., Tomas, D., & Horne, M. K. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.02.009 · Cited by 350
Retracted
Induction of the Unfolded Protein Response in Familial Amyotrophic Lateral Sclerosis and Association of Protein-disulfide Isomerase with Superoxide Dismutase 1
Atkin, J. D., Farg, M. A., Turner, B. J., Tomas, D., Lysaght, J. A., Nunan, J., Rembach, A., Nagley, P., Beart, P. M., Cheema, S. S., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603393200 · Cited by 289
Retracted
Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis
Rosen, D. R., Siddique, T., Patterson, D., Figlewicz, D. A., Sapp, P., Hentati, A., Donaldson, D., Goto, J., O'Regan, J. P., Deng, H.-X., et al. (1993) · Nature · doi:10.1038/362059a0 · Cited by 7,062
Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis
Neumann, M., Sampathu, D. M., Kwong, L. K., Truax, A. C., Micsenyi, M. C., Chou, T. T., Bruce, J., Schuck, T., Grossman, M., Clark, C. M., et al. (2006) · Science · doi:10.1126/science.1134108 · Cited by 6,576
Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS
DeJesus-Hernandez, M., Mackenzie, I. R., Boeve, B. F., Boxer, A. L., Baker, M., Rutherford, N. J., Nicholson, A. M., Finch, N. A., Flynn, H., Adamson, J., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.09.011 · Cited by 4,936
A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD
Renton, A. E., Majounie, E., Waite, A., Simón-Sánchez, J., Rollinson, S., Gibbs, J. R., Schymick, J. C., Laaksovirta, H., van Swieten, J. C., Myllykangas, L., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.09.010 · Cited by 4,409
Self-citation
Identification and characterization of a spinal muscular atrophy-determining gene
Lefebvre, S., Bürglen, L., Reboullet, S., Clermont, O., Burlet, P., Viollet, L., Bénichou, B., Cruaud, C., Millasseau, P., Zeviani, M., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90460-3 · Cited by 3,995
Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17
Hutton, M., Lendon, C. L., Rizzu, P., Baker, M., Froelich, S., Houlden, H., Pickering-Brown, S., Chakraverty, S., Isaacs, A., Grover, A., et al. (1998) · Nature · doi:10.1038/31508 · Cited by 3,498
TDP-43 Mutations in Familial and Sporadic Amyotrophic Lateral Sclerosis
Sreedharan, J., Blair, I. P., Tripathi, V. B., Hu, X., Vance, C., Rogelj, B., Ackerley, S., Durnall, J. C., Williams, K. L., Buratti, E., et al. (2008) · Science · doi:10.1126/science.1154584 · Cited by 2,630
Mutations in FUS, an RNA Processing Protein, Cause Familial Amyotrophic Lateral Sclerosis Type 6
Vance, C. A., Rogelj, B., Hortobágyi, T., Vos, K. J. D., Nishimura, A. L., Sreedharan, J., Hu, X., Smith, B. N., Ruddy, D., Wright, P. D., et al. (2009) · Science · doi:10.1126/science.1165942 · Cited by 2,625

Flagged first, then by citations

Show all 202 references

1 of the 202 references couldn’t be matched to a known paper.

Research works printed but not linked: 2

Fitzmaurice, P. S. et al. Evidence for DNA damage in amyotrophic lateral sclerosis. Muscle Nerve 19, 797–798 (1996).
Highley, J. R. et al. TARDBP mutations, amyotrophic lateral sclerosis and alternative splicing in human fibroblasts. Brain Pathol. 20 (Suppl. 1), 32 (2010).

Sorted by citations

Items 201–300 of 616

From basic research to the clinic: innovative therapies for ALS and FTD in the pipeline
Liščić, R. M., Alberici, A., Cairns, N. J., Romano, M., & Buratti, E. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-00373-9 · Cited by 48
Transplantation of clinical-grade human neural stem cells reduces neuroinflammation, prolongs survival and delays disease progression in the SOD1 rats
Zalfa, C., Nodari, L. R., Vacchi, E., Gelati, M., Profico, D. C., Boido, M., Binda, E., Filippis, L. D., Copetti, M., Garlatti, V., et al. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1582-5 · Cited by 44
Tardbpl splicing rescues motor neuron and axonal development in a mutant tardbp zebrafish
Hewamadduma, C., Grierson, A. J., Ma, T. P., Pan, L., Moens, C. B., Ingham, P. W., Ramesh, T., & Shaw, P. J. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt082 · Cited by 55
Self-citation
Overexpression of survival motor neuron improves neuromuscular function and motor neuron survival in mutant SOD1 mice
Turner, B. J., Alfazema, N., Sheean, R. K., Sleigh, J. N., Davies, K. E., Horne, M. K., & Talbot, K. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.09.030 · Cited by 43
Invited Review: Decoding the pathophysiological mechanisms that underlie RNA dysregulation in neurodegenerative disorders: a review of the current state of the art
Walsh, M. J., Cooper‐Knock, J., Dodd, J. E., Stopford, M. J., Mihaylov, S. R., Kirby, J., Shaw, P. J., & Hautbergue, G. M. (2014) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12187 · Cited by 46
Self-citation
Insulin-like growth factor 1 in diabetic neuropathy and amyotrophic lateral sclerosis
Rauskolb, S., Dombert, B., & Sendtner, M. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.04.007 · Cited by 45
Self-citation
In-vivo effects of knocking-down metabotropic glutamate receptor 5 in the SOD1 mouse model of amyotrophic lateral sclerosis
Bonifacino, T., Cattaneo, L., Gallia, E., Puliti, A., Melone, M., Provenzano, F., Bossi, S., Musante, I., Usai, C., Conti, F., et al. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.06.020 · Cited by 42
LanCL1 promotes motor neuron survival and extends the lifespan of amyotrophic lateral sclerosis mice
Tan, H., Chen, M., Pang, D., Xia, X., Du, C., Yang, W., Cui, Y., Huang, C., Jiang, W., Bi, D., et al. (2019) · Cell Death and Differentiation · doi:10.1038/s41418-019-0422-6 · Cited by 44
Micro-RNAs Shuttled by Extracellular Vesicles Secreted from Mesenchymal Stem Cells Dampen Astrocyte Pathological Activation and Support Neuroprotection in In-Vitro Models of ALS
Provenzano, F., Nyberg, S., Giunti, D., Torazza, C., Parodi, B., Bonifacino, T., Usai, C., de Rosbo, N. K., Milanese, M., Uccelli, A., et al. (2022) · Cells · doi:10.3390/cells11233923 · Cited by 47
Self-citation
Chitotriosidase and lysosomal enzymes as potential biomarkers of disease progression in amyotrophic lateral sclerosis: A survey clinic-based study
Pagliardini, V., Pagliardini, S., Corrado, L., Lucenti, A., Panigati, L., Bersano, E., Servo, S., Cantello, R., D'Alfonso, S., & Mazzini, L. (2015) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2014.12.016 · Cited by 42
Analysis of neuromuscular junctions and effects of anabolic steroid administration in the SOD1G93A mouse model of ALS
Cappello, V., Vezzoli, E., Righi, M., Fossati, M., Mariotti, R., Crespi, A., Patruno, M., Bentivoglio, M., Pietrini, G., & Francolini, M. (2012) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2012.07.003 · Cited by 44
Group I metabotropic glutamate autoreceptors induce abnormal glutamate exocytosis in a mouse model of amyotrophic lateral sclerosis
Giribaldi, F., Milanese, M., Bonifacino, T., Rossi, P. I. A., Prisco, S. D., Pittaluga, A., Tacchetti, C., Puliti, A., Usai, C., & Bonanno, G. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.05.018 · Cited by 43
The proteasome regulator PI31 is required for protein homeostasis, synapse maintenance, and neuronal survival in mice
Minis, A., Rodriguez, J. A., Levin, A., Liu, K., Govek, E., Hatten, M. E., & Steller, H. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1911921116 · Cited by 43
Omics Approach to Axonal Dysfunction of Motor Neurons in Amyotrophic Lateral Sclerosis (ALS)
Suzuki, N., Akiyama, T., Warita, H., & Aoki, M. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00194 · Cited by 46
Death receptor 6 (DR6) antagonist antibody is neuroprotective in the mouse SOD1G93A model of amyotrophic lateral sclerosis
Huang, G., Lee, X., Bian, Y., Shao, Z., Sheng, G.-N., Pepinsky, R. B., & Mi, S. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.378 · Cited by 42
RBM45 homo-oligomerization mediates association with ALS-linked proteins and stress granules
Li, Y., Collins, M. A., Geiser, R., Bakkar, N., Riascos, D., & Bowser, R. P. (2015) · Scientific Reports · doi:10.1038/srep14262 · Cited by 41
Metabo-lipidomics of Fibroblasts and Mitochondrial-Endoplasmic Reticulum Extracts from ALS Patients Shows Alterations in Purine, Pyrimidine, Energetic, and Phospholipid Metabolisms
Veyrat‐Durebex, C., Bris, C., Codron, P., Bocca, C., Chupin, S., Corcia, P., Vourc’h, P., Hergesheimer, R. C., Cassereau, J., Funalot, B., et al. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-1484-7 · Cited by 41
Early gene expression changes in spinal cord from SOD1G93A Amyotrophic Lateral Sclerosis animal model
de Oliveira, G. P., Alves, C. J., & Chadi, G. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00216 · Cited by 40
ALS Patient Stem Cells for Unveiling Disease Signatures of Motoneuron Susceptibility: Perspectives on the Deadly Mitochondria, ER Stress and Calcium Triad
Kaus, A. S., & Sareen, D. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00448 · Cited by 42
Soluble RAGE Treatment Delays Progression of Amyotrophic Lateral Sclerosis in SOD1 Mice
Juranek, J. K., Daffu, G. K., Geddis, M. S., Li, H., Rosario, R., Kaplan, B. J., Kelly, L. A., & Schmidt, A. M. (2016) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2016.00117 · Cited by 40
ALS-related FUS mutations alter axon growth in motoneurons and affect HuD/ELAVL4 and FMRP activity
Garone, M. G., Birsa, N., Rosito, M., Salaris, F., Mochi, M., de Turris, V., Nair, R., Cunningham, T. J., Fisher, E., Morlando, M., et al. (2021) · Communications Biology · doi:10.1038/s42003-021-02538-8 · Cited by 41
Highly Immunoreactive IgG Antibodies Directed against a Set of Twenty Human Proteins in the Sera of Patients with Amyotrophic Lateral Sclerosis Identified by Protein Array
May, C., Nordhoff, E., Casjens, S., Turewicz, M., Eisenacher, M., Gold, R., Brüning, T., Pesch, B., Stephan, C., Woitalla, D., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089596 · Cited by 40
An Early Onset Progressive Motor Neuron Disorder inScyl1-Deficient Mice Is Associated with Mislocalization of TDP-43
Pelletier, S. W., Gingras, S., Howell, S. R., Vogel, P., & Ihle, J. N. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.1787-12.2012 · Cited by 39
Alternative splicing in aging and age-related diseases
Li, H., Wang, Z., Ma, T., Wei, G., & Ni, T. (2017) · Translational Medicine of Aging · doi:10.1016/j.tma.2017.09.005 · Cited by 40
Additional evidence for a therapeutic effect of dextromethorphan/quinidine on bulbar motor function in patients with amyotrophic lateral sclerosis: A quantitative speech analysis
Green, J. R., Allison, K. M., Cordella, C., Richburg, B. D., Pattee, G. L., Berry, J. D., Macklin, E. A., Pioro, E. P., & Smith, R. A. (2018) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13745 · Cited by 39
Voltage-gated calcium channels are abnormal in cultured spinal motoneurons in the G93A-SOD1 transgenic mouse model of ALS
Chang, Q., & Martin, L. J. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.04.009 · Cited by 43
Mitochondrial Dyshomeostasis as an Early Hallmark and a Therapeutic Target in Amyotrophic Lateral Sclerosis
Belosludtseva, N. V., Matveeva, L. A., & Belosludtsev, K. N. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242316833 · Cited by 40
Genetically altering organismal metabolism by leptin-deficiency benefits a mouse model of amyotrophic lateral sclerosis
Lim, M. A., Bence, K. K., Sandesara, I., Andreux, P. A., Auwerx, J. H., Ishibashi, J., Seale, P., & Kalb, R. G. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu214 · Cited by 37
Gene panels and primers for next generation sequencing studies on neurodegenerative disorders
Giau, V. V., An, S. S. A., Bagyinszky, E., & Kim, S. (2015) · Molecular & Cellular Toxicology · doi:10.1007/s13273-015-0011-9 · Cited by 37
Pathological mechanisms of amyotrophic lateral sclerosis
Hu, Y., Chen, W., Wei, C., Jiang, S., Li, S., Wang, X., & Xu, R. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.382985 · Cited by 39
The rho kinase inhibitor Y-27632 improves motor performance in male SOD1G93A mice
nther, R. G. ⁄., Saal, K., Suhr, M., Scheer, D., Koch, J. C., Bähr, M., Lingor, P., & Tönges, L. (2014) · Frontiers in Neuroscience · doi:10.3389/fnins.2014.00304 · Cited by 36
Motor and extra-motor gray matter atrophy in amyotrophic lateral sclerosis: quantitative meta-analyses of voxel-based morphometry studies
Sheng, L., Ma, H., Zhong, J., Shang, H., Shi, H., & Pan, P. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.08.018 · Cited by 37
Repurposing carbamazepine for the treatment of amyotrophic lateral sclerosis in SOD1‐G93A mouse model
Zhang, J., Zhou, Q., Chen, S., & Le, W. (2018) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12855 · Cited by 36
C9ORF72-related cellular pathology in skeletal myocytes derived from ALS-patient induced pluripotent stem cells
Lynch, E. M., Semrad, T., Belsito, V. S., FitzGibbons, C., Reilly, M. L., Hayakawa, K., & Suzuki, M. (2019) · Disease Models & Mechanisms · doi:10.1242/dmm.039552 · Cited by 37
UBQLN2 restrains the domesticated retrotransposon PEG10 to maintain neuronal health in ALS
Black, H. H., Hanson, J. L., Roberts, J. E., Leslie, S. N., Campodonico-Burnett, W., Ebmeier, C. C., Holling, G. A., Tay, J. W., Matthews, A. M., Ung, E., et al. (2023) · eLife · doi:10.7554/elife.79452 · Cited by 34
Protein SUMOylation, an emerging pathway in amyotrophic lateral sclerosis
Dangoumau, A., Veyrat‐Durebex, C., Blasco, H., Praline, J., Corcia, P., Andres, C. R., & Vourc’h, P. (2013) · International Journal of Neuroscience · doi:10.3109/00207454.2012.761984 · Cited by 38
Human Pluripotent Stem Cells: Applications and Challenges in Neurological Diseases
Hibaoui, Y., & Féki, A. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00267 · Cited by 35
γ-Oryzanol mitigates oxidative stress and prevents mutant SOD1-Related neurotoxicity in Drosophila and cell models of amyotrophic lateral sclerosis
Zhang, C., Liang, W., Wang, H., Yang, Y., Wang, T., Wang, S., Wang, X., Wang, Y., & Feng, H. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.107777 · Cited by 34
Astrocyte regional diversity in ALS includes distinct aberrant phenotypes with common and causal pathological processes
Gomes, C., Sequeira, C., Barbosa, M., Cunha, C., Vaz, A. R., & Brites, D. M. T. O. (2020) · Experimental Cell Research · doi:10.1016/j.yexcr.2020.112209 · Cited by 40
SRSF1-dependent inhibition of C9ORF72-repeat RNA nuclear export: genome-wide mechanisms for neuroprotection in amyotrophic lateral sclerosis
Castelli, L. M., Cutillo, L., Souza, C. D. S., Sánchez-Martínez, Á., Granata, I., Lin, Y.-H., Myszczynska, M. A., Heath, P. R., Livesey, M. R., Ning, K., et al. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00475-y · Cited by 34
Self-citation
In Vitro 3D Modeling of Neurodegenerative Diseases
Louit, A., Galbraith, T., & Berthod, F. (2023) · Bioengineering · doi:10.3390/bioengineering10010093 · Cited by 37
Deregulated expression of cytoskeleton related genes in the spinal cord and sciatic nerve of presymptomatic SOD1G93A Amyotrophic Lateral Sclerosis mouse model
Maximino, J. R., de Oliveira, G. P., Alves, C. J., & Chadi, G. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00148 · Cited by 36
Neurotrophic factors in the physiology of motor neurons and their role in the pathobiology and therapeutic approach to amyotrophic lateral sclerosis
Stansberry, W. M., & Pierchala, B. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1238453 · Cited by 34
Adipose Tissue-Derived Stem Cells in Neural Regenerative Medicine
Yeh, D.-C., Chan, T.-M., Harn, H.-J., Chiou, T., Chen, H.-S., Lin, Z.-S., & Lin, S. (2015) · Cell Transplantation · doi:10.3727/096368915x686940 · Cited by 32
Shared Mechanisms between Drosophila Peripheral Nervous System Development and Human Neurodegenerative Diseases
Charng, W., Yamamoto, S., & Bellen, H. J. (2014) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2014.03.001 · Cited by 29
Amyotrophic lateral sclerosis: Is the spinal fluid pathway involved in seeding and spread?
Smith, R. A., Myers, K. J., Ravits, J., & Bowser, R. P. (2015) · Medical Hypotheses · doi:10.1016/j.mehy.2015.07.014 · Cited by 34
Stem cells for ALS: An overview of possible therapeutic approaches
Czarzasta, J., Habich, A., Siwek, T., Czapliński, A., Maksymowicz, W., & Wojtkiewicz, J. (2017) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2017.01.003 · Cited by 33
MyomiRNAs Dysregulation in ALS Rehabilitation
Pegoraro, V., Merico, A., & Angelini, C. I. (2019) · Brain Sciences · doi:10.3390/brainsci9010008 · Cited by 35
The involvement of regulatory T cells in amyotrophic lateral sclerosis and their therapeutic potential
Giovannelli, I., Heath, P. R., Shaw, P. J., & Kirby, J. (2020) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2020.1752246 · Cited by 39
Self-citation
Understanding Abnormal c-JNK/p38MAPK Signaling in Amyotrophic Lateral Sclerosis: Potential Drug Targets and Influences on Neurological Disorders
Yadav, R. K., Minz, E., & Mehan, S. (2021) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527320666210126113848 · Cited by 34
Mitochondrial metals as a potential therapeutic target in neurodegeneration
Grubman, A., White, A. R., & Liddell, J. R. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12513 · Cited by 33
VDAC1: A Key Player in the Mitochondrial Landscape of Neurodegeneration
Argueti-Ostrovsky, S., Barel, S., Kahn, J., & Israelson, A. (2024) · Biomolecules · doi:10.3390/biom15010033 · Cited by 31
Retinoids and motor neuron disease: Potential role in amyotrophic lateral sclerosis
Riancho, J., Berciano, M. T., Ruiz‐Soto, M., Berciano, J., Landreth, G. E., & Lafarga, M. (2015) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2015.11.058 · Cited by 31
The therapeutic potential of cell identity reprogramming for the treatment of aging-related neurodegenerative disorders
Smith, D. K., He, M., Zhang, C., & Zheng, J. (2016) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.01.006 · Cited by 34
Transplantation of mesenchymal stem cells in ALS
Mazzini, L., Vercelli, A., Ferrero, I., Boido, M., Cantello, R. M., & Fagioli, F. (2012) · Progress in brain research · doi:10.1016/b978-0-444-59544-7.00016-0 · Cited by 32
Trace elements in ALS patients and their relationships with clinical severity
Oggiano, R., Solinas, G., Forte, G., Bocca, B., Farace, C., Pisano, A., Sotgiu, M. A., Clemente, S., Malaguarnera, M., Fois, A. G., et al. (2018) · Chemosphere · doi:10.1016/j.chemosphere.2018.01.076 · Cited by 32
Altered glucose catabolism in the presynaptic and perisynaptic compartments of SOD1G93A mouse spinal cord and motor cortex indicates that mitochondria are the site of bioenergetic imbalance in ALS
Ravera, S., Torazza, C., Bonifacino, T., Provenzano, F., Rebosio, C., Milanese, M., Usai, C., Panfoli, I., & Bonanno, G. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14819 · Cited by 33
Deregulated miR-29b-3p Correlates with Tissue-Specific Activation of Intrinsic Apoptosis in An Animal Model of Amyotrophic Lateral Sclerosis
Klatt, C. L., Theis, V., Hahn, S. A., Theiß, C., & Matschke, V. (2019) · Cells · doi:10.3390/cells8091077 · Cited by 31
Plant-Derived Natural Compounds for the Treatment of Amyotrophic Lateral Sclerosis: An Update
Mohi-ud-din, R., Mir, R. H., Shah, A. J., Sabreen, S., Wani, T. U., Masoodi, M. H., Akkol, E. K., Bhat, Z. A., & Khan, H. Z. (2021) · Current Neuropharmacology · doi:10.2174/1570159x19666210428120514 · Cited by 34
Computing Stability Effects of Mutations in Human Superoxide Dismutase 1
Kepp, K. P. (2014) · The Journal of Physical Chemistry B · doi:10.1021/jp4119138 · Cited by 31
Gem Depletion: Amyotrophic Lateral Sclerosis and Spinal Muscular Atrophy Crossover
Cauchi, R. J. (2014) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12242 · Cited by 31
Neurofilament depletion improves microtubule dynamics via modulation of Stat3/stathmin signaling
Yadav, P., Selvaraj, B. T., Bender, F. L. P., Behringer, M., Moradi, M., Sivadasan, R., Dombert, B., Blum, R., Asan, E., Sauer, M., et al. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1564-y · Cited by 33
Self-citation
Single-Fluorophore Indicator to Explore Cellular and Sub-cellular Lactate Dynamics
Aburto, C., Galaz, A., Bernier, A., Sandoval, P. Y., Holtheuer-Gallardo, S., Ruminot, I., Soto-Ojeda, I., Hertenstein, H., Schweizer, J., Schirmeier, S., et al. (2022) · ACS Sensors · doi:10.1021/acssensors.2c00731 · Cited by 31
No evidence for shared genetic basis of common variants in multiple sclerosis and amyotrophic lateral sclerosis
Goris, A., van Setten, J., Diekstra, F. P., Ripke, S., Patsopoulos, N. A., Sawcer, S. J., van Es, M. A., Andersen, P. M., Melki, J., Meininger, V., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt574 · Cited by 30
Clinical and genetic basis of familial amyotrophic lateral sclerosis
de Souza, P. V. S., Pinto, W. B. V. D. R., Chieia, M. A. T., & Oliveira, A. S. B. (2015) · Arquivos de Neuro-Psiquiatria · doi:10.1590/0004-282x20150161 · Cited by 31
Hyperexcitability in synaptic and firing activities of spinal motoneurons in an adult mouse model of amyotrophic lateral sclerosis
Jiang, M. C., Adimula, A., Birch, D. V., & Heckman, C. J. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2017.08.041 · Cited by 31
Towards Understanding the Relationship Between ER Stress and Unfolded Protein Response in Amyotrophic Lateral Sclerosis
Zhao, C., Liao, Y., Rahaman, A., & Kumar, V. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.892518 · Cited by 32
TDP-43—The key to understanding amyotrophic lateral sclerosis
Xu, Z., & Yang, C. (2014) · Rare Diseases · doi:10.4161/21675511.2014.944443 · Cited by 36
Novel Neuroprotective Multicomponent Therapy for Amyotrophic Lateral Sclerosis Designed by Networked Systems
Herrando‐Grabulosa, M., Mulet‐Lazaro, R., Pujol, A., Mas, J. M., Navarro, X., Aloy, P., Coma, M., & Casas, C. (2016) · PLoS ONE · doi:10.1371/journal.pone.0147626 · Cited by 30
Bid Promotes K63-Linked Polyubiquitination of Tumor Necrosis Factor Receptor Associated Factor 6 (TRAF6) and Sensitizes to MutantSOD1-Induced Proinflammatory Signaling in Microglia
Kinsella, S. M., König, H., & Prehn, J. H. M. (2016) · eNeuro · doi:10.1523/eneuro.0099-15.2016 · Cited by 30
Major Histocompatibility Complex I Expression by Motor Neurons and Its Implication in Amyotrophic Lateral Sclerosis
Nardo, G., Trolese, M. C., & Bendotti, C. (2016) · Frontiers in Neurology · doi:10.3389/fneur.2016.00089 · Cited by 32
Proteomic profiling of the spinal cord in ALS: decreased ATP5D levels suggest synaptic dysfunction in ALS pathogenesis
Engelen-Lee, J.-Y., Blokhuis, A. M., Spliet, W. G. M., Pasterkamp, R. J., Aronica, E., Demmers, J., Broekhuizen, R., Nardo, G., Bovenschen, N., & van den Berg, L. H. (2016) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2016.1245757 · Cited by 31
Disulfide cross-linked multimers of TDP-43 and spinal motoneuron loss in a TDP-43A315T ALS/FTD mouse model
Bargsted, L., Medinas, D. B., Traub, F. M., Rozas, P., Muñoz, N., Nassif, M., Jerez, C., Catenaccio, A., Court, F. A., Hetz, C. A., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-14399-5 · Cited by 30
Maximizing the Survival of Amyotrophic Lateral Sclerosis Patients: Current Perspectives
Khairoalsindi, O. A., & Abuzinadah, A. R. (2018) · Neurology Research International · doi:10.1155/2018/6534150 · Cited by 35
Regulation of Intracellular Copper by Induction of Endogenous Metallothioneins Improves the Disease Course in a Mouse Model of Amyotrophic Lateral Sclerosis
Tokuda, E., Watanabe, S., Okawa, E., & Ono, S.-I. (2015) · Neurotherapeutics · doi:10.1007/s13311-015-0346-x · Cited by 31
H63D HFE genotype accelerates disease progression in animal models of amyotrophic lateral sclerosis
Nandar, W., Neely, E. B., Simmons, Z., & Connor, J. R. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.09.016 · Cited by 29
Power Failure of Mitochondria and Oxidative Stress in Neurodegeneration and Its Computational Models
Woo, J., Cho, H., Seol, Y., Kim, S. H., Park, C., Yousefian-Jazi, A., Hyeon, S. J., Lee, J.-H., & Ryu, H. (2021) · Antioxidants · doi:10.3390/antiox10020229 · Cited by 32
Blocking glutamate mGlu 5 receptors with the negative allosteric modulator CTEP improves disease course in SOD1 G93A mouse model of amyotrophic lateral sclerosis
Milanese, M., Bonifacino, T., Torazza, C., Provenzano, F., Kumar, M., Ravera, S., Zerbo, R. A., Frumento, G., Balbi, M., Nguyen, T. P. N., et al. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15515 · Cited by 30
Comparison of Blood RNA Extraction Methods Used for Gene Expression Profiling in Amyotrophic Lateral Sclerosis
Bayatti, N., Cooper‐Knock, J., Bury, J. J., Wyles, M., Heath, P. R., Kirby, J., & Shaw, P. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087508 · Cited by 29
Self-citation
New In Vitro Models to Study Amyotrophic Lateral Sclerosis
Myszczynska, M. A., & Ferraiuolo, L. (2016) · Brain Pathology · doi:10.1111/bpa.12353 · Cited by 31
Self-citation
Cerebrospinal fluid and blood exosomes as biomarkers for amyotrophic lateral sclerosis; a systematic review
Darabi, S., Ariaei, A., Rustamzadeh, A., Afshari, D., Gorgich, E. A. C., & Darabi, L. (2024) · Diagnostic Pathology · doi:10.1186/s13000-024-01473-6 · Cited by 31
Simvastatin accelerated motoneurons death in SOD1G93A mice through inhibiting Rab7-mediated maturation of late autophagic vacuoles
Bai, L., Wang, Y., Huo, J., Li, S., Wen, Y., Liu, Q., Yang, J., Liu, Y., & Li, R. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03669-w · Cited by 29
Translatomic analysis of regenerating and degenerating spinal motor neurons in injury and ALS
Shadrach, J. L., Stansberry, W. M., Milen, A. M., Ives, R. E., Fogarty, E. A., Antonellis, A., & Pierchala, B. A. (2021) · iScience · doi:10.1016/j.isci.2021.102700 · Cited by 25
AI-based protein structure databases have the potential to accelerate rare diseases research: AlphaFoldDB and the case of IAHSP/Alsin
Sebastiano, M. R., Ermondi, G., Hadano, S., & Caron, G. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2021.12.018 · Cited by 28
Proteinopathies as Hallmarks of Impaired Gene Expression, Proteostasis and Mitochondrial Function in Amyotrophic Lateral Sclerosis
Benson, B. C., Shaw, P. J., Azzouz, M., Highley, J. R., & Hautbergue, G. M. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.783624 · Cited by 30
Self-citation
Microglial crosstalk with astrocytes and immune cells in amyotrophic lateral sclerosis
Calafatti, M., Cocozza, G., Limatola, C., & Garofalo, S. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1223096 · Cited by 29
Role of calpain-1 in the early phase of experimental ALS
Stifanese, R., Averna, M., TULLIO, R. D., Pedrazzi, M., Milanese, M., Bonifacino, T., Bonanno, G., Salamino, F., Pontremoli, S., & Melloni, E. (2014) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2014.08.006 · Cited by 28
TDP-43: A new player on the AD field?
Youmans, K. L., & Wolozin, B. L. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2012.05.018 · Cited by 28
The C‐terminal domain of tetanus toxin protects motoneurons against acute excitotoxic damage on spinal cord organotypic cultures
Herrando‐Grabulosa, M., Casas, C., & Aguilera, J. (2012) · Journal of Neurochemistry · doi:10.1111/jnc.12062 · Cited by 27
Overexpression of the Cdk5 inhibitory peptide in motor neurons rescue of amyotrophic lateral sclerosis phenotype in a mouse model
Binukumar, B. K., Skuntz, S., Prochazkova, M., Kesavapany, S., Amin, N. D., Shukla, V., Grant, P. G., Kulkarni, A. B., & Pant, H. C. (2019) · Human Molecular Genetics · doi:10.1093/hmg/ddz118 · Cited by 27
Enhanced Function and Overexpression of Metabotropic Glutamate Receptors 1 and 5 in the Spinal Cord of the SOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis during Disease Progression
Bonifacino, T., Rebosio, C., Provenzano, F., Torazza, C., Balbi, M., Milanese, M., Raiteri, L., Usai, C., Fedele, E., & Bonanno, G. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20184552 · Cited by 27
Review: Microglia in motor neuron disease
Ashford, B., Boche, D., Cooper‐Knock, J., Heath, P. R., Simpson, J. E., & Highley, J. R. (2020) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12640 · Cited by 27
Amyotrophic lateral sclerosis transcriptomics reveals immunological effects of low-dose interleukin-2
Giovannelli, I., Bayatti, N., Brown, A. G., Wang, D. Y. Q., Mickunas, M., Camu, W., Veyrune, J., Payan, C., Garlanda, C., Locati, M., et al. (2021) · Brain Communications · doi:10.1093/braincomms/fcab141 · Cited by 27
Self-citation
TorsinA rescues ER-associated stress and locomotive defects in C. elegans models of ALS
Thompson, M. L., Chen, P., Yan, X., Kim, H., Borom, A. R., Roberts, N. B., Caldwell, K. A., & Caldwell, G. A. (2013) · Disease Models & Mechanisms · doi:10.1242/dmm.013615 · Cited by 27
Steroid Profiling in Male Wobbler Mouse, a Model of Amyotrophic Lateral Sclerosis
Deniselle, M. C. G., Lière, P., Pianos, A., Meyer, M., Aprahamian, F., Cambourg, A., Giorgio, N. P. D., Schumacher, M., Nicola, A. F. D., & Guennoun, R. (2016) · Endocrinology · doi:10.1210/en.2016-1244 · Cited by 27
Neuroinflammation and Neurodegeneration
Morales, I., Farias, G. A., Cortés, N., & Maccioni, R. B. (2016) · InTech eBooks · doi:10.5772/64545 · Cited by 34
Elevated NLRP3 Inflammasome Activation Is Associated with Motor Neuron Degeneration in ALS
Cihankaya, H., Bader, V., Winklhofer, K. F., Vorgerd, M., Matschke, J., Stahlke, S., Theiß, C., & Matschke, V. (2024) · Cells · doi:10.3390/cells13120995 · Cited by 28
Glucose Metabolic Reprogramming in Microglia: Implications for Neurodegenerative Diseases and Targeted Therapy
Fang, M., Zhou, Y., He, K., Lu, Y., Tao, F., & Huang, H. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-04775-y · Cited by 33
Activation of the Nrf2 Pathway as a Therapeutic Strategy for ALS Treatment
Arslanbaeva, L. R., & Bisaglia, M. (2022) · Molecules · doi:10.3390/molecules27051471 · Cited by 27
Accumulation of misfolded SOD1 outlines distinct patterns of motor neuron pathology and death during disease progression in a SOD1G93A mouse model of amyotrophic lateral sclerosis
Salvany, S., Casanovas, A., Piedrafita, L., Gras, S., Calderó, J., & Esquerda, J. E. (2022) · Brain Pathology · doi:10.1111/bpa.13078 · Cited by 26

Authors: Ferraiuolo, L., Kirby, J., Grierson, A. J., Sendtner, M., & Shaw, P. J.
Affiliations: University of Sheffield (GB)
University of Würzburg (DE)
Corresponding author: Shaw, Pamela J.
ORCID: Ferraiuolo, Laura
Kirby, Janine
Grierson, Andrew J.
Sendtner, Michael
Shaw, Pamela J.
Venue: Nature Reviews Neurology
Publisher: Springer Science and Business Media LLC
Published: 2011-11
Volume: 7
Issue: 11
Pages: 616-630
ISSN: 1759-4758 (ISSN-L)
1759-4766
DOI: 10.1038/nrneurol.2011.152
OpenAlex: W2025413109
Cited by: 615
References: 202
Citations by year: 2026: 12 · 2025: 24 · 2024: 34 · 2023: 25 · 2022: 27 · 2021: 54 · 2020: 34 · 2019: 37 · 2018: 33 · 2017: 42 · 2016: 58 · 2015: 63 · 2014: 63 · 2013: 64 · 2012: 45
FWCI: 6.83
Type: journal article
Language: en
Open access: green
zenodo.org
Licence: other-oa
www.springer.com/tdm (tdm)
Locations: Nature Reviews Neurology (publishedVersion)
PubMed (publishedVersion)
Zenodo (CERN European Organization for Nuclear Research) (submittedVersion, other-oa)
Funders: Wellcome Trust
Topics: Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Hereditary Neurological Disorders
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Keywords: amyotrophic lateral sclerosis, motor neuron injury, motor neuron degeneration, oxidative stress, mitochondrial dysfunction, excitotoxicity, superoxide dismutase 1, TDP-43, sporadic ALS, familial ALS, therapeutic target
MeSH terms: Amyotrophic Lateral Sclerosis, Humans, Motor Neurons, Nerve Degeneration

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Molecular pathways of motor neuron injury in amyotrophic lateral sclerosis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks